VS

Vidya Selvi

Director Director DIN 07280758
DIN 07280758 First appointment Aug 2015 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Vidya Selvi

Data last updated:

Vidya Selvi was a Director at 6Th Skin Pharmaceuticals Private Limited (2015–2017) and Additional Director at Uniderm Pharmaceuticals Private Limited (from 2015). The companies operate in Chemicals and Materials.

DIN 07280758
Primary Designation Director
Industry Chemicals and Materials
First Appointment 25 Aug 2015
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20152013₹1.08 Cr (FY 2016)Active
Additional Director23 Oct 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Uniderm Pharmaceuticals Private Limited
6Th Skin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vidya Selvi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidya Selvi

Vidya Selvi was first appointed on 25 Aug 2015 as Director at 6Th Skin Pharmaceuticals Private Limited.

Vidya Selvi held 2 earlier board appointments: 6Th Skin Pharmaceuticals Private Limited (Director, 25 Aug 2015 to 24 Feb 2017); Uniderm Pharmaceuticals Private Limited (Additional Director, from 23 Oct 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available